Market Overview

Rett Syndrome| A Pipeline Analysis Report 2018| Technavio


Technavio has announced their latest pipeline analysis report on the Rett
syndrome market
. The report includes a detailed analysis of the
pipeline molecules under investigation within the defined data
collection period to treat Rett syndrome.

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for Rett syndrome, including a ...

Technavio has published a new report on the drug development pipeline for Rett syndrome, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Rett syndrome: Market overview

Rett syndrome is one of the rare genetic neurological disorders. It
majorly affects the development of the brain and further leads to the
inability of a person to use muscles for body movements and speech. It
can also result in seizures and intellectual disability.

According to a senior market research analyst at Technavio, "Long-time
complications of Rett syndrome can result in difficulty in eating,
constipation, unusual sleep patterns, and muscle and joint problems. As
a result, with increasing incidences of the syndrome, the need for drug
development for Rett syndrome is expected to increase considerably in
the next few years."

Rett syndrome: Segmentation analysis

This pipeline analysis report segments the Rett syndrome market based on
therapies employed (monotherapy), RoA (oral, subcutaneous, and
intrathecal), therapeutic modality (small molecule, gene therapy and
protein), targets (CDKLS protein, glutamate, microglia, NMDA receptor,
mitochondrial protein, serotonin, sphingosine-1-phosphate receptor, and
LSD1), MoA (NMDA receptor agonist, mitochondrial protein modulator,
serotonin receptor, sphingosine-1-phosphate receptor stimulator, CDKLS
protein replacement, glutamate modulator, and LSD1 inhibitor),
geographical segmentation (US, Switzerland, Australia, India, Italy, and
UK) and recruitment status (active, not recruiting, completed, and
recruiting). It provides an in-depth analysis of the prominent factors
influencing the market, including drivers, opportunities, trends, and
industry-specific challenges.

Based on therapeutic modality, about 61% of the molecules that are being
investigated for the treatment of Rett syndrome are small molecule.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!